These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10826950)

  • 1. Natural catalytic immunity is not restricted to autoantigenic substrates: identification of a human immunodeficiency virus gp 120-cleaving antibody light chain.
    Paul S; Kalaga RS; Gololobov G; Brenneman D
    Appl Biochem Biotechnol; 2000; 83(1-3):71-82; discussion 82-4, 145-53. PubMed ID: 10826950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
    Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
    J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain.
    Hifumi E; Mitsuda Y; Ohara K; Uda T
    J Immunol Methods; 2002 Nov; 269(1-2):283-98. PubMed ID: 12379368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
    Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
    J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    Wen Y; Trinh HV; Linton CE; Tani C; Norais N; Martinez-Guzman D; Ramesh P; Sun Y; Situ F; Karaca-Griffin S; Hamlin C; Onkar S; Tian S; Hilt S; Malyala P; Lodaya R; Li N; Otten G; Palladino G; Friedrich K; Aggarwal Y; LaBranche C; Duffy R; Shen X; Tomaras GD; Montefiori DC; Fulp W; Gottardo R; Burke B; Ulmer JB; Zolla-Pazner S; Liao HX; Haynes BF; Michael NL; Kim JH; Rao M; O'Connell RJ; Carfi A; Barnett SW
    PLoS One; 2018; 13(4):e0194266. PubMed ID: 29698406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
    Planque S; Mitsuda Y; Taguchi H; Salas M; Morris MK; Nishiyama Y; Kyle R; Okhuysen P; Escobar M; Hunter R; Sheppard HW; Hanson C; Paul S
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1541-54. PubMed ID: 18160012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
    Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
    Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes.
    Zaghouani H; Goldstein D; Shah H; Anderson S; Lacroix M; Dionne G; Kennedy R; Bona C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5645-9. PubMed ID: 2062842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS.
    Page M; Vella C; Corcoran T; Dilger P; Ling C; Heath A; Thorpe R
    AIDS; 1992 May; 6(5):441-6. PubMed ID: 1616648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1.
    Hifumi E; Okamoto Y; Uda T
    Appl Biochem Biotechnol; 2000; 83(1-3):209-19; discussion 219-20, 297-313. PubMed ID: 10826961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
    Pinter A; Honnen WJ; Racho ME; Tilley SA
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.
    Tyutyulkova S; Gao QS; Thompson A; Rennard S; Paul S
    Biochim Biophys Acta; 1996 Aug; 1316(3):217-23. PubMed ID: 8781541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody repertoire against HIV-1 gp120 triggered in nude and normal mice by GM-CSF/gp120 immunization.
    del Real G; Llorente M; Lucas P; Kremer L; Torán JL; Martínez-A C
    Mol Immunol; 1999 Aug; 36(11-12):721-31. PubMed ID: 10593511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development.
    Scandella CJ; Kilpatrick J; Lidster W; Parker C; Moore JP; Moore GK; Mann KA; Brown P; Coates S; Chapman B
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1233-44. PubMed ID: 8142140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.